| Term | Count | % | | OCULAR HYPERAEMIA | 463 | 9.38% |
| EYE IRRITATION | 422 | 8.55% |
| EYE PAIN | 293 | 5.94% |
| EYE PRURITUS | 228 | 4.62% |
| DRUG INEFFECTIVE | 208 | 4.21% |
| DEATH | 198 | 4.01% |
| VISION BLURRED | 169 | 3.42% |
| HEADACHE | 165 | 3.34% |
| EYE SWELLING | 122 | 2.47% |
| DRY EYE | 109 | 2.21% |
| INTRAOCULAR PRESSURE INCREASED | 96 | 1.94% |
| PHOTOPHOBIA | 86 | 1.74% |
| LACRIMATION INCREASED | 74 | 1.50% |
| DIZZINESS | 72 | 1.46% |
| DYSPNOEA | 69 | 1.40% |
| HYPERSENSITIVITY | 65 | 1.32% |
| OFF LABEL USE | 63 | 1.28% |
| FATIGUE | 57 | 1.15% |
| PRURITUS | 56 | 1.13% |
| COUGH | 52 | 1.05% |
| VISUAL IMPAIRMENT | 50 | 1.01% |
| PAIN | 45 | 0.91% |
| NAUSEA | 44 | 0.89% |
| EYE DISCHARGE | 42 | 0.85% |
| RASH | 42 | 0.85% |
| PRODUCT DOSE OMISSION ISSUE | 41 | 0.83% |
| GLAUCOMA | 40 | 0.81% |
| URINARY TRACT INFECTION | 40 | 0.81% |
| OCULAR DISCOMFORT | 39 | 0.79% |
| DIARRHOEA | 38 | 0.77% |
| ERYTHEMA | 38 | 0.77% |
| FOREIGN BODY SENSATION IN EYES | 37 | 0.75% |
| PRODUCT QUALITY ISSUE | 35 | 0.71% |
| ARTHRALGIA | 33 | 0.67% |
| NO ADVERSE EVENT | 32 | 0.65% |
| FALL | 31 | 0.63% |
| DRUG HYPERSENSITIVITY | 29 | 0.59% |
| NASOPHARYNGITIS | 28 | 0.57% |
| ERYTHEMA OF EYELID | 27 | 0.55% |
| INSOMNIA | 27 | 0.55% |
| WRONG TECHNIQUE IN PRODUCT USAGE PROCESS | 27 | 0.55% |
| ALOPECIA | 26 | 0.53% |
| BLOOD PRESSURE INCREASED | 26 | 0.53% |
| CATARACT | 26 | 0.53% |
| CEREBROVASCULAR ACCIDENT | 26 | 0.53% |
| VISUAL ACUITY REDUCED | 26 | 0.53% |
| DRUG DOSE OMISSION | 25 | 0.51% |
| EYE INFLAMMATION | 25 | 0.51% |
| MALAISE | 25 | 0.51% |
| RHINORRHOEA | 25 | 0.51% |
| DYSPHONIA | 23 | 0.47% |
| OROPHARYNGEAL PAIN | 23 | 0.47% |
| SYNCOPE | 23 | 0.47% |
| ASTHENIA | 22 | 0.45% |
| BLEPHARITIS | 22 | 0.45% |
| DRY MOUTH | 22 | 0.45% |
| EYELID IRRITATION | 22 | 0.45% |
| HYPERTENSION | 22 | 0.45% |
| COVID-19 | 21 | 0.43% |
| MUSCULAR WEAKNESS | 21 | 0.43% |
| ABNORMAL SENSATION IN EYE | 20 | 0.41% |
| CONSTIPATION | 20 | 0.41% |
| PAIN IN EXTREMITY | 20 | 0.41% |
| TREATMENT FAILURE | 20 | 0.41% |
| BURNING SENSATION | 19 | 0.38% |
| DRUG INTERACTION | 19 | 0.38% |
| SKIN DISCOLOURATION | 19 | 0.38% |
| BLINDNESS | 18 | 0.36% |
| EYELIDS PRURITUS | 18 | 0.36% |
| MYOCARDIAL INFARCTION | 18 | 0.36% |
| PNEUMONIA | 18 | 0.36% |
| SKIN EXFOLIATION | 18 | 0.36% |
| DEPRESSION | 17 | 0.34% |
| EYELID OEDEMA | 17 | 0.34% |
| PRODUCT USE ISSUE | 17 | 0.34% |
| SWELLING OF EYELID | 17 | 0.34% |
| ARRHYTHMIA | 16 | 0.32% |
| CHEST DISCOMFORT | 16 | 0.32% |
| MUSCLE SPASMS | 16 | 0.32% |
| PARAESTHESIA | 16 | 0.32% |
| PRODUCT USE IN UNAPPROVED INDICATION | 16 | 0.32% |
| SWELLING FACE | 16 | 0.32% |
| ABDOMINAL DISCOMFORT | 15 | 0.30% |
| BACK PAIN | 15 | 0.30% |
| CONDITION AGGRAVATED | 15 | 0.30% |
| DYSGEUSIA | 15 | 0.30% |
| EYELID MARGIN CRUSTING | 15 | 0.30% |
| HALLUCINATION | 15 | 0.30% |
| OVERDOSE | 15 | 0.30% |
| PALPITATIONS | 15 | 0.30% |
| PRODUCT STORAGE ERROR | 15 | 0.30% |
| SOMNOLENCE | 15 | 0.30% |
| ABDOMINAL PAIN UPPER | 14 | 0.28% |
| BALANCE DISORDER | 14 | 0.28% |
| BLOOD GLUCOSE INCREASED | 14 | 0.28% |
| DRY SKIN | 14 | 0.28% |
| EYE HAEMORRHAGE | 14 | 0.28% |
| INCORRECT DOSE ADMINISTERED | 14 | 0.28% |
| PEMPHIGOID | 14 | 0.28% |
| PERIPHERAL SWELLING | 14 | 0.28% |
| Total | 4936 | |